Ældre patienter En populationsfarmakokinetisk analyse af HIV- inficerede patienter viste, at farmakokinetikken for darunavir ikke er meget anderledes i aldersgruppen 18- 75 år vurderet hos HIV- inficerede patienter (n=12, alder ≥ 65 år) (se pkt.
Elderly Population pharmacokinetic analysis in HIV infected patients showed that darunavir pharmacokinetics are not considerably different in the age range (18 to 75 years) evaluated in HIV infected patients (n=12, age ≥ 65) (see section 4.4).